Department of Internal Medicine, Clinic III-Hematology, Oncology and Palliative Care, Rostock University Medical Center, Rostock, Germany.
Institute of Biostatistics and Informatics in Medicine, Rostock University Medical Center, Rostock, Germany.
PLoS One. 2024 Aug 22;19(8):e0301304. doi: 10.1371/journal.pone.0301304. eCollection 2024.
Patients with head and neck cancer (PwHNC) benefit from targeted exercise interventions: symptom relief, compensation for dysfunction, improvement in quality of life (QoL). Data on acceptance physical interventions in PwHNC are rare. The 'OSHO #94' trial investigates the short- and medium-term effects of individualized home exercise in PwHNC on QoL, physical activity and functionality. The study includes a feasibility phase (proof of concept) in order to evaluate the acceptance. Here we present the study protocol as well as the feasibility results.
This prospective, multicentre, single-arm intervention study includes PwHNC ≥18 years of age in aftercare or palliative care with stable remission under immunotherapy. The study opened in January 01, 2021, with estimated completion by December 31, 2024. The PwHNC receive an individualized home exercise program consisting of mobilization, coordination, strengthening and stretching exercises. This should be carried out at least three times a week over 12 weeks for 15 to 30 minutes, supplemented by aerobic training two to three times a week for 30 minutes (intervention). Once weekly telephone calls with a physiotherapist are performed. Subsequently, there is a 12-week follow-up (FU) without exercise specifications/contact. Outcomes are measured before and after the intervention and following the FU. Primary outcome of the feasibility phase (n = 25) was the determination of the dropout rate during the intervention with a termination cut off if more than 30% PwHNC withdrew premature. The primary outcome of the OSHO #94' trial (N = 53) is the change in global QoL score from pre- to post-intervention (EORTC QLQ-C30). Secondary outcomes include clinical and patient-reported measures, training details as well as functional diagnostic data (e.g. level of physical activity, training frequency, flexibility, fall risk and aerobic performance).
25 PwHNC were enrolled onto the feasibility cohort. Only16% (4/25 patients) did not complete the study. Therefore, recruitment of PwHNC was continued. The dropout rate was adjusted from 30% (N = 60) to 20% (N = 53, calculated sample size n = 42 PwHNC and 20% (n = 11) to dropout).
Individualized home exercise programs in PwHNC in aftercare seem feasible. Consequently, the aim is now to evaluate the short and medium-term effects of individualized home exercise.
患有头颈部癌症(PwHNC)的患者受益于靶向运动干预:缓解症状、代偿功能障碍、提高生活质量(QoL)。关于 PwHNC 接受身体干预的数据很少。'OSHO #94' 试验调查了 PwHNC 个体化家庭运动对 QoL、身体活动和功能的短期和中期影响。该研究包括可行性阶段(概念验证),以评估接受度。这里我们展示了研究方案以及可行性结果。
这是一项前瞻性、多中心、单臂干预研究,包括年龄在 18 岁及以上、处于免疫治疗后康复或姑息治疗阶段、缓解稳定的 PwHNC。该研究于 2021 年 1 月 1 日开始,预计于 2024 年 12 月 31 日完成。PwHNC 接受个体化家庭运动方案,包括动员、协调、强化和伸展运动。这应在 12 周内每周至少进行三次,每次 15 至 30 分钟,每周两次至三次进行有氧训练,每次 30 分钟(干预)。每周一次与物理治疗师进行电话联系。随后,进行 12 周的随访(FU),不规定运动方案/不联系。在干预前后和 FU 后测量结果。可行性阶段(n = 25)的主要结果是确定干预期间的辍学率,如果超过 30%的 PwHNC 过早退出,则终止。'OSHO #94' 试验(N = 53)的主要结果是从干预前到干预后的全球 QoL 评分变化(EORTC QLQ-C30)。次要结果包括临床和患者报告的测量、培训详细信息以及功能诊断数据(例如身体活动水平、训练频率、灵活性、跌倒风险和有氧表现)。
25 名 PwHNC 被纳入可行性队列。只有 16%(25 名患者中的 4 名)未完成研究。因此,继续招募 PwHNC。将辍学率从 30%(N = 60)调整为 20%(N = 53,计算样本量 n = 42 名 PwHNC 和 20%(n = 11)至辍学)。
PwHNC 在康复后的个体化家庭运动方案似乎是可行的。因此,现在的目标是评估个体化家庭运动的短期和中期效果。